3 ms·
The problem with right-to-try is that it's framed as "Big Bad Pharma (and/or FDA's onerous regulations) is preventing these life-saving cures from getting to pe
by jcranmer 8y ago
The problem with right-to-try is that it's framed as "Big Bad Pharma (and/or FDA's onerous regulations) is preventing these life-saving cures from getting to people, we need to get them sooner." Yet the experimental evidence is most drug candidates fail because they don't work. Even the big, expensive phase III trials have about a 50% failure rate. If you're pushing for access much earlier (concurrent with phase I), that means you're pushing for access before there's data on how lethal the drug is.
Derek's big concern with right-to-try is that it's basically a way to advocate for taking the science out of drug approval. Data outside of a well-controlled study is hard to use, but the public will lobby for it to be used. And the concern isn't idle: when the FDA's response to the bill was "we're going to look into how to do this safely," the reply form a key Senator was "no, no, no, you don't understand, we're trying to tell you to get out of the way." The end goal would be to eliminate the FDA as useless bureaucracy, but we already have an example of what unregulated drug industry looks like: it's called the health supplements industry, which is so sleazy that many companies don't even bother to include the active ingredients they claim to include.
- olliej 8y agoDon't forget Thalidomide, etc. People seem to forget that there was a time where the FDA and trials didn't exist. And that the reason the FDA has to exist is because otherwise you get very expensive "drugs" that frequent, at best, do nothing, and oftentimes do harm.
- djrogers 8y ago> If you're pushing for access much earlier (concurrent with phase I) Nobody is doing that - current RTT legislation only applies to treatments that have passed phase I, not drugs that are in or have not yet started phase I trials.